Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

48.46
Delayed Data
As of Jul 31
 +0.10 / +0.21%
Today’s Change
22.12
Today|||52-Week Range
52.10
+52.97%
Year-to-Date

Today’s Trading

Previous close48.36
Today’s open48.65
Day’s range46.52 - 48.91
Volume889,166
Average volume (3 months)772,592
Market cap$3.5B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-44.90%
Earnings growth (this year)+6.69%
Earnings growth (next 5 years)+23.40%
Revenue growth (last year)+16.53%
P/E ratio76.4
Price/Sales3.75
Price/Book3.95

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc+0.47+0.56%
INSYINSYS Therapeutics I...+0.90+2.04%
CBPOChina Biologic Produ...+2.57+2.15%
GRFSGrifols SA-0.45-1.37%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)$0.36
Annual revenue (last year)$596.0M
Annual profit (last year)$57.4M
Net profit margin9.62%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts